{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:44:27Z","timestamp":1794617067323,"version":"4.9.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science and Technology Plan Project of Shannan Municipal Science and Technology Bureau","award":["No.SNSBJKJJHXM2025023 to LC"],"award-info":[{"award-number":["No.SNSBJKJJHXM2025023 to LC"]}],"id":[{"id":"https:\/\/ror.org\/05sx6be47","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,19]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The liver is pivotal in the metabolic and innate immune responses of sepsis, managing bacteremia, cytokine regulation, and acute-phase protein synthesis. However, the liver\u2019s susceptibility to damage during sepsis underscores the need to understand the mechanisms behind septic liver injury. Our objective was to apply bioinformatics to identify key genes and pathways involved in septic liver injury and to reveal potential therapeutic targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We utilized pubmed2ensembl to identify genes associated with septic liver injury and performed functional annotation and pathway analysis using Xiantao. Protein-protein interactions were analyzed via the STRING database, and hub genes were identified with Cytoscape software. Candidate genes were validated with Metascape, and drug-gene interactions were explored using DGIDB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Our analysis identified 63 genes implicated in sepsis-associated liver injury, refining our understanding of its molecular landscape. Gene ontology and Kyoto encyclopedia of genes and genomes analyses shortlisted 42 candidate genes, highlighting their roles in septic liver injury pathogenesis. An PPI network analysis extracted 18 genes, with MCODE-assisted analysis revealing a module of 8 key genes central to septic liver injury pathophysiology. These genes \u2013 TLR4, CXCL8, IL-18, IL-6, IL1B, tumor necrosis factor, NFKB1, and colony-stimulating factor 3 \u2013 are linked to 3 major signaling pathways: malaria, legionellosis, and the cellular response to lipopolysaccharide. Furthermore, 23 drugs targeting these genes were identified, suggesting their potential as therapeutic agents for septic liver injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The genes TLR4, CXCL8, IL-18, IL-6, IL1B, tumor necrosis factor, NFKB1, and colony-stimulating factor 3 are central to the pathology of septic liver injury, acting as critical mediators of associated inflammatory processes. The correspondence of these genes with 23 drugs demonstrates their therapeutic potential, elucidating molecular targets for future interventions and paving the way for novel treatment strategies. This study provides a robust framework for subsequent research endeavors and the development of targeted therapies, enhancing our capacity to address septic liver injury effectively.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049060","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:01:48Z","timestamp":1782108108000},"page":"e49060","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Identification of potential hub genes and drugs in septic liver injury: A bioinformatic analysis"],"prefix":"10.1097","volume":"105","author":[{"given":"Yan","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, The First People\u2019s Hospital of Jiangxia District, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"},{"name":"Department of Anesthesiology, Shannan Maternal and Child Health Hospital, Shannan, Xizang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The First People\u2019s Hospital of Jiangxia District, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0985-1510","authenticated-orcid":false,"given":"Rui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Zhejiang Hospital, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261113","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41419-018-0838-9","article-title":"Overexpression of homeodomain-interacting protein kinase 2 (HIPK2) attenuates sepsis-mediated liver injury by restoring autophagy.","volume":"9","author":"Jiang","year":"2018","journal-title":"Cell Death Dis"},{"key":"R2-20261113","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","article-title":"Liver - guardian, modifier and target of sepsis.","volume":"14","author":"Strnad","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R3-20261113","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3390\/biom11101430","article-title":"Text mining for building biomedical networks using cancer as a case study.","volume":"11","author":"Concei\u00e7\u00e3o","year":"2021","journal-title":"Biomolecules"},{"key":"R4-20261113","doi-asserted-by":"crossref","first-page":"e0184129","DOI":"10.1371\/journal.pone.0184129","article-title":"Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways.","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"R5-20261113","doi-asserted-by":"crossref","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the drug-gene interaction database (DGIdb 4.0) with open crowdsource efforts.","volume":"49","author":"Freshour","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"R6-20261113","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","article-title":"Cytoscape stringapp: network analysis and visualization of proteomics data.","volume":"18","author":"Doncheva","year":"2019","journal-title":"J Proteome Res"},{"key":"R7-20261113","doi-asserted-by":"crossref","first-page":"e7873","DOI":"10.7717\/peerj.7873","article-title":"Identification of crucial genes in abdominal aortic aneurysm by WGCNA.","volume":"7","author":"Chen","year":"2019","journal-title":"PeerJ"},{"key":"R8-20261113","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"R9-20261113","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.intimp.2019.03.021","article-title":"Hydrogen gas inhalation attenuates sepsis-induced liver injury in a FUNDC1-dependent manner.","volume":"71","author":"Yan","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"R10-20261113","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1186\/s13054-020-03327-1","article-title":"Gut-liver crosstalk in sepsis-induced liver injury.","volume":"24","author":"Sun","year":"2020","journal-title":"Crit Care"},{"key":"R11-20261113","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/22221751.2022.2045876","article-title":"Metformin attenuated sepsis-related liver injury by modulating gut microbiota.","volume":"11","author":"Liang","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"R12-20261113","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cca.2022.10.004","article-title":"Clinical characteristics and construction of a predictive model for patients with sepsis related liver injury.","volume":"537","author":"Xie","year":"2022","journal-title":"Clin Chim Acta"},{"key":"R13-20261113","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41401-020-00597-x","article-title":"Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis.","volume":"42","author":"Chen","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"R14-20261113","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.7150\/thno.15625","article-title":"Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases.","volume":"7","author":"Ha","year":"2017","journal-title":"Theranostics"},{"key":"R15-20261113","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1067\/msy.2003.189","article-title":"Interleukin-12 and -18 induce severe liver injury in mice recovered from peritonitis after sublethal endotoxin challenge.","volume":"134","author":"Ono","year":"2003","journal-title":"Surgery"},{"key":"R16-20261113","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/intimm\/11.3.471","article-title":"IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock.","volume":"11","author":"Sakao","year":"1999","journal-title":"Int Immunol"},{"key":"R17-20261113","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000505099","article-title":"Interleukin-6: a masterplayer in the cytokine network.","volume":"98","author":"Uciechowski","year":"2020","journal-title":"Oncology (Huntingt)"},{"key":"R18-20261113","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature11603","article-title":"Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability.","volume":"492","author":"Zhu","year":"2012","journal-title":"Nature"},{"key":"R19-20261113","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1172\/JCI136908","article-title":"IL-1\u03b2 suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury.","volume":"130","author":"Xiong","year":"2020","journal-title":"J Clin Invest"},{"key":"R20-20261113","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies.","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"R21-20261113","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/febs.13627","article-title":"NFKB1: a suppressor of inflammation, ageing and cancer.","volume":"283","author":"Cartwright","year":"2016","journal-title":"FEBS J"},{"key":"R22-20261113","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nbd.2013.12.003","article-title":"Complex regulation of acute and chronic neuroinflammatory responses in mouse models deficient for nuclear factor kappa B p50 subunit.","volume":"64","author":"Rolova","year":"2014","journal-title":"Neurobiol Dis"},{"key":"R23-20261113","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3390\/cells10061562","article-title":"Eritoran attenuates hepatic inflammation and fibrosis in mice with chronic liver injury.","volume":"10","author":"Hsieh","year":"2021","journal-title":"Cells"},{"key":"R24-20261113","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1586\/eri.11.27","article-title":"Toll-like receptor-4 antagonist eritoran tetrasodium for severe sepsis.","volume":"9","author":"Tidswell","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R25-20261113","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/mol.110.068064","article-title":"TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules.","volume":"79","author":"Matsunaga","year":"2011","journal-title":"Mol Pharmacol"},{"key":"R26-20261113","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/187152810793358796","article-title":"Population pharmacokinetic evaluation of a fully human IgG monoclonal antibody in patients with inflammatory diseases.","volume":"9","author":"Tabrizi","year":"2010","journal-title":"Inflamm Allergy Drug Targets"},{"key":"R27-20261113","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2165\/00128071-200809050-00004","article-title":"Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape.","volume":"9","author":"Zigler","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"R28-20261113","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1586\/eri.12.115","article-title":"Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients.","volume":"10","author":"Bacigalupo","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R29-20261113","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00003495-199448020-00007","article-title":"Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.","volume":"48","author":"Wagstaff","year":"1994","journal-title":"Drugs"},{"key":"R30-20261113","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.yrtph.2017.12.005","article-title":"Historical evolution of regulatory standards for occupational and consumer exposures to industrial talc.","volume":"92","author":"Drechsel","year":"2018","journal-title":"Regul Toxicol Pharmacol"},{"key":"R31-20261113","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.athoracsur.2019.08.104","article-title":"Talc pleurodesis: a medical, medicolegal, and socioeconomic review.","volume":"109","author":"Baiu","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"R32-20261113","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1470-2045(14)70319-5","article-title":"Siltuximab for multicentric Castleman\u2019s disease: a randomised, double-blind, placebo-controlled trial.","volume":"15","author":"van Rhee","year":"2014","journal-title":"Lancet Oncol"},{"key":"R33-20261113","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jocd.2022.12.003","article-title":"Olokizumab\u2019s effectiveness and safety in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials.","volume":"26","author":"Mahmoud","year":"2023","journal-title":"J Clin Densitom"},{"key":"R34-20261113","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ekir.2022.01.1074","article-title":"Evaluation of clazakizumab (anti-interleukin-6) in patients with treatment-resistant chronic active antibody-mediated rejection of kidney allografts.","volume":"7","author":"Jordan","year":"2022","journal-title":"Kidney Int Rep"},{"key":"R35-20261113","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/annrheumdis-2016-209668","article-title":"Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial.","volume":"76","author":"Wallace","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R36-20261113","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1517\/13543784.2014.950837","article-title":"Sirukumab : a novel therapy for lupus nephritis?","volume":"23","author":"Thanarajasingam","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"R37-20261113","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/mabs.2.1.10328","article-title":"Canakinumab.","volume":"2","author":"Dhimolea","year":"2010","journal-title":"MAbs"},{"key":"R38-20261113","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14712598.2022.2005024","article-title":"Rilonacept for the treatment of recurrent pericarditis.","volume":"22","author":"Fava","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"R39-20261113","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2337\/dc11-2219","article-title":"Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.","volume":"35","author":"Cavelti-Weder","year":"2012","journal-title":"Diabetes Care"},{"key":"R40-20261113","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/ALN.0b013e318253a02a","article-title":"TT-301 inhibits microglial activation and improves outcome after central nervous system injury in adult mice.","volume":"116","author":"James","year":"2012","journal-title":"Anesthesiology"},{"key":"R41-20261113","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.gastro.2013.05.048","article-title":"Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.","volume":"146","author":"Sandborn","year":"2014","journal-title":"Gastroenterology"},{"key":"R42-20261113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exphem.2020.09.199","article-title":"Eflapegrastim\u2019s enhancement of efficacy compared with pegfilgrastim in neutropenic rats supports potential for same-day dosing.","volume":"92","author":"Barrett","year":"2020","journal-title":"Exp Hematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:04:14Z","timestamp":1794585854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":42,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049060","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"2025-01-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}